Subscribe to our newsletter

GPP (Generalized Pustular Psoriasis) Registry

CorEvitas is now part of Thermo Fisher Scientific. Read More.

About Generalized Pustular Psoriasis

Generalized Pustular Psoriasis (GPP) is a rare disease affecting an estimated one out of every 10,000 people in the U.S., with most studies showing it affects more women than men. It is characterized by the sudden widespread eruption of rash and sterile pustules, with or without systemic inflammation, recurring from once a year to more than three times a year. These flares are often accompanied by severe complications which, if left untreated, can be life threatening.

About our GPP Registry

This registry prospectively collect detailed patient-level data enabling assessment of the natural history of the disease and treatment patterns, along with the prevalence and incidence of comorbidities in patients with the disease.

Granular, longitudinal outcome measures will be collected during registry visits, some of which include clinician-reported GPP outcomes, lab measures and treatment history, as well as patient-reported outcomes assessing symptom impact and quality of life. Drug safety data also will be collected, including serious adverse events and other adverse events of special interest.

Read the Press Release, here.

Clinical outcome measures and PROs in the CorEvitas GPP Registry.

Among the variables we collect, some of the key outcome measures to inform your research include:

Clinician Reported Outcomes

Patient Reported Outcomes

Registry Scientific Advisors

Picture of Mark Lebwohl, MD

Mark Lebwohl, MD

Dean for Clinical Therapeutics, Icahn School of Medicine at Mount Sinai | Professor and Chairman Emeritus of the Kimberly and Eric J. Waldman Department of Dermatology at Mount Sinai | Past president, American Academy of Dermatology | Chairman emeritus, Medical Board of the National Psoriasis Foundation

Picture of Bruce Strober, MD, PhD, FAAD

Bruce Strober, MD, PhD, FAAD

Clinical Professor, Department of Dermatology, Yale University | Clinician, Central Connecticut Dermatology | Vice President/President-Elect, International Psoriasis Council | Editor in Chief of the Journal of Psoriasis and Psoriatic Arthritis | Former Chair of Dermatology at the University of Connecticut Health Center